(Q43691285)

English

The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice

scientific article published in January 1988

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

J J Hoogeterp

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Mattie

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P Terporten

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

58-62

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative determination of the effect of granulocytes on the course of experimental infections during antibiotic treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relative potency of amoxycillin and ampicillin in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of the newer quinolones compared with the classic ones and tobramycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3129373

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01646935

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43691285&oldid=2206206356"